IBEX Medical Systems-preview

Ibex-co

IBEX Medical Systems

Private

South KoreaHealthcare & Life Scienceshttps://ibex.co.kr/kr/

Last Round

Series C

May 16, 2025

Est. Valuation

$57.61M

Total Funding Raised

$15.99M

Momentum Score

50 /100

Company Overview

IBEX Medical Systems is a medical device company that manufactures and distributes hyperbaric oxygen therapy (HBOT) chambers.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Sensors

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts, Services & Consulting

AI Layer

Application

Keywords

hyperbaric oxygen therapyHBOThyperbaric chambermedical device manufactureroxygen therapy deviceMonoplace chamberMultiplace chamberbarotrauma preventionAnti-Barotrauma technologyremote patient monitoringAI-augmented medical devicetranscutaneous oxygen monitoringtcpO2 monitoringhyperhidrosis treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

IBEX Medical Systems Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

IBEX Medical Systems Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Series C	May 16, 2025
Series A	Nov 10, 2020

View all Funding Rounds

Key People

Founding team and executive leadership

Brian SOKO YOON

CEO

Executive Team

IBEX Medical Systems Investors

Notable investors and investment history

Investor	Rounds
Smilegate Investment	Series B
ROI Investment Partners	Series C
KB Financial Group	Series C
Lifecore Partners	Series A
Capstone Partners Korea	Series B
Tigris Investment	Series A
Industrial Bank of Korea	Series C

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 13, 2026
Grew 60% QoQ, from 5 to 8 employees.
May 16, 2025
$9.66M round led by E&Investment.

View all signals

IBEX Medical Systems Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

IBEX Medical Systems Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about IBEX Medical Systems's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth Korea

Employee Range8

Year Founded2000

Last FundingMay 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.